News

Deal Announcements

OptMed Secures $6 Million More Venture Capital

Monday, May 2, 2011 5:57:00 AM PDT | VentureDeal Staff
   New York, New York  --  Biosurgical technology company OptMed has garnered $6 million in new venture capital investment, according to an SEC regulatory filing.

OptMed is developing a topical skin adhesive as a replacement for surgical sutures.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

OptMed is still seeking an additional $20 million in the round, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1